KISCO logo

KISCO

Asia, Osaka, Japan, Osaka

Description

KISCO specializes in the sales of pharmaceutical products and semiconductor devices.

Investor Profile

KISCO has made 2 investments, with 1 in the past 12 months and 0% as lead.

Stage Focus

  • Series D (50%)
  • Series A (50%)

Country Focus

  • Japan (100%)

Industry Focus

  • Biotechnology
  • Medical
  • Nursing And Residential Care
  • Health Care
  • Outsourcing
  • Test And Measurement
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does KISCO frequently co-invest with?

Iwagin Jigyo Souzou Capital
Asia, Iwate, Japan, Morioka
Co-Investments: 1
Mizuho Capital
Asia, Tokyo, Japan, Tokyo
Co-Investments: 2
Newton Biocapital
Europe, Brussels Hoofdstedelijk Gewest, Belgium, Brussels
Co-Investments: 1
KSP
Asia, Tokyo, Japan, Tokyo
Co-Investments: 1
Fidea Capital
Asia, Yamagata, Japan, Yamagata
Co-Investments: 1
KNC Laboratories
Asia, Kyoto, Japan, Kobe
Co-Investments: 1
F-Prime Capital
North America, Massachusetts, United States, Cambridge
Co-Investments: 1
Nippon Venture Capital
Asia, Tokyo, Japan, Tokyo
Co-Investments: 1
Mitsubishi UFJ Capital
Asia, Tokyo, Japan, Tokyo
Co-Investments: 1
MBLVC
Asia, Aichi, Japan, Nagoya
Co-Investments: 1

What are some of recent deals done by KISCO?

Gaudi Clinical

Hongo, Tokyo, Japan

Gaudi Clinical is a health care firm that engages in regenerative medicine outsourcing and cell processing contract establishments.

Health CareOutsourcingTest and Measurement
Series AFeb 7, 2025
Amount Raised: $8,918,073
J-Pharma

Yokohama, Kanagawa, Japan

J-Pharma is biotechnology company mission is to creating and developing novel pharmaceuticals.

BiotechnologyMedicalNursing and Residential Care
Series DJul 30, 2020
Amount Raised: $16,678